FDA reverses stance on autism drug
The US Food and Drug Administration is no longer recommending a high-dose B vitamin medication (leucovorin) as a potential treatment for autism. Last fall, Health and Human Services Secretary Robert Kennedy Jr. claimed the drug could be a therapy for thousands of children with the condition.
March 11, 2026
Takeaways from the latest California governor’s debate
Camp Mystic hearing takeaways: Apologies, flood plan failures, and pushback on reopening after 27 deaths
Tracy Sturdivant, the Ms. Foundation's next leader, wants to expand the feminist funder's coalition
Pastrnak scores 9:14 into OT and Bruins avoid elimination with 2-1 win over Sabres
Red cards can be given to players who cover their mouths while confronting opponents
Mexican man pleads guilty to impersonating Border Patrol agent to 'disrupt deportation missions'
NCAA’s March Madness field could grow to 76 teams for 2027 season
High-level talks begin on moving away from fossil fuels at Colombia conference
Joel Embiid scores 33 as 76ers beat Celtics 113-97 in Game 5 to keep their season alive